Risk Factors for Rescue Therapy in Crohn's Patients on Combination Therapy After Discontinuation of the Immunomodulator

被引：0
|
作者：
Fischer, Monika
Campbell, Sarah C.
Johnson, Cynthia S.
Helper, Debra J.
Chiorean, Michael V.
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1373
引用
收藏
页码：S450 / S450
页数：1
相关论文
共 50 条
  • [31] Risk factors that predict the requirement of aggressive therapy among Chinese patients with Crohn's disease
    Yang, Chuan Hua
    Ding, Juan
    Gao, Yan
    Chen, Xiang
    Yang, Zhao Bin
    Xiao, Shu Dong
    JOURNAL OF DIGESTIVE DISEASES, 2011, 12 (02) : 99 - 104
  • [32] THE COURSE OF INFLIXIMAB DISCONTINUATION AFTER LONG-TERM MAINTENANCE THERAPY IN CROHN'S DISEASE
    Armuzzi, A.
    Rizzi, M.
    Monterubbianesi, R.
    Marzo, M.
    Cicala, M.
    Guidi, L.
    Prantera, C.
    Kohn, A.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S135 - S135
  • [33] Oral Squamous Cell Carcinoma in a Crohn's Disease Patient on Immunomodulator Therapy
    Sandhu, Hasnoor
    Mann, Rupinder
    Sekhon, Sandeep
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1024 - S1025
  • [34] Risk factors for discontinuation of insulin pump therapy in pediatric and young adult patients
    Kostev, Karel
    Rockel, Timo
    Rosenbauer, Joachim
    Rathmann, Wolfgang
    PRIMARY CARE DIABETES, 2014, 8 (04) : 346 - 351
  • [35] Infliximab Therapy Impacts the Peripheral Immune System of Immunomodulator and Corticosteroid Naive Patients with Crohn's Disease
    Kato, Kyoichi
    Fukunaga, Ken
    Kamikozuru, Koji
    Kashiwamura, Shinichiro
    Hida, Nobuyuki
    Ohda, Yoshio
    Takeda, Naohisa
    Yoshida, Koji
    Iimuro, Masaki
    Yokoyama, Yoko
    Kikuyama, Risa
    Miwa, Hiroto
    Matsumoto, Takayuki
    GUT AND LIVER, 2011, 5 (01) : 37 - 45
  • [36] Concomitant Immunomodulator and Infliximab Therapy for Crohn's Disease: A Survey of Physician Practice
    Vajravelu, Ravy
    Katz, Jeffry
    GASTROENTEROLOGY, 2010, 138 (05) : S702 - S702
  • [37] APPROPRIATENESS OF CONCOMITANT IMMUNOMODULATOR AND BIOLOGIC THERAPY IN CROHN'S DISEASE AND ULCERATIVE COLITIS
    Melmed, Gil
    Kaplan, Gilaad
    Sparrow, Miles
    Velayos, Fernando
    Baidoo, Leonard
    Bressler, Brian
    Cheifetz, Adam S.
    Devlin, Shane M.
    Irving, Peter M.
    Jones, Jennifer L.
    Kozuch, Patricia
    Raffals, Laura H.
    Siegel, Corey A.
    GASTROENTEROLOGY, 2017, 152 (05) : S590 - S590
  • [38] Symptomatic gastroduodenal Crohn's disease (GCD) requires aggressive immunomodulator therapy
    Selby, L
    De Villiers, WJS
    Annis, K
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S272 - S273
  • [39] Infliximab as Rescue Therapy for Hospitalized Patients With Crohn's Disease Failing Intravenous Corticosteroids
    Patel, Anish Vinit
    Moore, Jacqueline
    Sultan, Keith
    AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (06) : E611 - E615
  • [40] Infliximab as Rescue Therapy for Hospitalized Patients With Crohn's Disease Failing Intravenous Corticosteroids
    Patel, Anish V.
    Moore, Jacqueline M.
    Sultan, Keith
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S336 - S337
12345